MarketBeat
09 May 2026, 09:07 UTC · 27w ago
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030
Verdict
Headline takes no side. We score TRVI +0.80 across five claims — strongly bullish.
- Expected · TRVI
+0.80strongly bullish
−1 bearish0bullish +1More positive than 88% of ticker scores this week
- Actual





